Ayuvis Research INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersFort Worth, TX
SAM.gov UEIE3H4XC65GZU3
AyuVis is developing immunotherapies using small molecules to prevent and treat life-threatening diseases including bronchopulmonary dysplasia, retinopathy of prematurity, and pulmonary arterial hypertension. The company's approach involves modulating white blood cells to address inflammation and infection in ICU patients, with small molecules designed to be simple to synthesize and produce. The therapies are intended to serve patients with conditions that currently lack effective treatment options.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Ayuvis Research INC | Fort Worth | TX | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.